img

Global Muscarinic Acetylcholine Receptor M4 Market Segment Research Report 2024

Published on: 2024-01-04 | No of Pages : 420 | Industry : Pharma & Healthcare Research Center

Publisher : MRX | Format : PDF

Global Muscarinic Acetylcholine Receptor M4 Market Segment Research Report 2024

Summary

The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.

2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.

According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.

Beijing Yanjing Bizhi Information Consulting Co., Ltd. （XYZResearch）released the 《(Post-pandemic Era)-Global Muscarinic Acetylcholine Receptor M4 Market Segment Research Report 2022》, which aims to sort out the development status and trends of the Muscarinic Acetylcholine Receptor M4 industry at home and abroad, estimate the overall market scale of the Muscarinic Acetylcholine Receptor M4 industry and the market share of major countries, Muscarinic Acetylcholine Receptor M4 industry, and study and judge the downstream market demand of Muscarinic Acetylcholine Receptor M4 through systematic research, Analyze the competition pattern of Muscarinic Acetylcholine Receptor M4, so as to help solve the pain points of various stakeholders in Muscarinic Acetylcholine Receptor M4 industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.

Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Muscarinic Acetylcholine Receptor M4 Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Muscarinic Acetylcholine Receptor M4 Market?
Anavex Life Sciences Corp
AstraZeneca Plc
Heptares Therapeutics Ltd
Karuna Pharmaceuticals Inc
NeuroHealing Pharmaceuticals Inc
Sumitomo Dainippon Pharma Co Ltd
Major Type of Muscarinic Acetylcholine Receptor M4 Covered in XYZResearch report
Tropicamide
ANAVEX-273
VU-0467154
Others
Application Segments Covered in XYZResearch Market
Cognitive Disorders
Psychosis
Amnesia
Others

For any other requirements, please feel free to contact us and we will provide you customized report.

Table of Content

Table of Contents

Global Muscarinic Acetylcholine Receptor M4 Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Muscarinic Acetylcholine Receptor M4 Market by Value
2.2.1 Global Muscarinic Acetylcholine Receptor M4 Revenue by Type
2.2.2 Global Muscarinic Acetylcholine Receptor M4 Market by Value (%)
2.3 Global Muscarinic Acetylcholine Receptor M4 Market by Production
2.3.1 Global Muscarinic Acetylcholine Receptor M4 Production by Type
2.3.2 Global Muscarinic Acetylcholine Receptor M4 Market by Production (%)

3. The Major Driver of Muscarinic Acetylcholine Receptor M4 Industry
3.1 Historical & Forecast Global Muscarinic Acetylcholine Receptor M4 Demand
3.2 Largest Application for Muscarinic Acetylcholine Receptor M4 (2018-2028)
3.3 The Major Downstream Company in China Market 2022

4. Global and Regional Muscarinic Acetylcholine Receptor M4 Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Muscarinic Acetylcholine Receptor M4 Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US Muscarinic Acetylcholine Receptor M4 Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

6. Europe Muscarinic Acetylcholine Receptor M4 Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

7. China Muscarinic Acetylcholine Receptor M4 Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

8. Japan Muscarinic Acetylcholine Receptor M4 Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

9. India Muscarinic Acetylcholine Receptor M4 Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

10. Korea Muscarinic Acetylcholine Receptor M4 Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

11. Southeast Asia Muscarinic Acetylcholine Receptor M4 Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

12. Global Muscarinic Acetylcholine Receptor M4 Average Price Trend
12.1 Market Price for Each Type of Muscarinic Acetylcholine Receptor M4 in US (2018-2022)
12.2 Market Price for Each Type of Muscarinic Acetylcholine Receptor M4 in Europe (2018-2022)
12.3 Market Price for Each Type of Muscarinic Acetylcholine Receptor M4 in China (2018-2022)
12.4 Market Price for Each Type of Muscarinic Acetylcholine Receptor M4 in Japan (2018-2022)
12.5 Market Price for Each Type of Muscarinic Acetylcholine Receptor M4 in India (2018-2022)
12.6 Market Price for Each Type of Muscarinic Acetylcholine Receptor M4 in Korea (2018-2022)
12.7 Market Price for Each Type of Muscarinic Acetylcholine Receptor M4 in Southeast Asia (2018-2022)

13. Industrial Chain (Impact of COVID-19)
13.1 Muscarinic Acetylcholine Receptor M4 Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Muscarinic Acetylcholine Receptor M4

14. Muscarinic Acetylcholine Receptor M4 Competitive Landscape
14.1 Anavex Life Sciences Corp
14.1.1 Anavex Life Sciences Corp Company Profiles
14.1.2 Anavex Life Sciences Corp Product Introduction
14.1.3 Anavex Life Sciences Corp Muscarinic Acetylcholine Receptor M4 Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 AstraZeneca Plc
14.2.1 AstraZeneca Plc Company Profiles
14.2.2 AstraZeneca Plc Product Introduction
14.2.3 AstraZeneca Plc Muscarinic Acetylcholine Receptor M4 Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Heptares Therapeutics Ltd
14.3.1 Heptares Therapeutics Ltd Company Profiles
14.3.2 Heptares Therapeutics Ltd Product Introduction
14.3.3 Heptares Therapeutics Ltd Muscarinic Acetylcholine Receptor M4 Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Karuna Pharmaceuticals Inc
14.4.1 Karuna Pharmaceuticals Inc Company Profiles
14.4.2 Karuna Pharmaceuticals Inc Product Introduction
14.4.3 Karuna Pharmaceuticals Inc Muscarinic Acetylcholine Receptor M4 Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 NeuroHealing Pharmaceuticals Inc
14.5.1 NeuroHealing Pharmaceuticals Inc Company Profiles
14.5.2 NeuroHealing Pharmaceuticals Inc Product Introduction
14.5.3 NeuroHealing Pharmaceuticals Inc Muscarinic Acetylcholine Receptor M4 Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Sumitomo Dainippon Pharma Co Ltd
14.6.1 Sumitomo Dainippon Pharma Co Ltd Company Profiles
14.6.2 Sumitomo Dainippon Pharma Co Ltd Product Introduction
14.6.3 Sumitomo Dainippon Pharma Co Ltd Muscarinic Acetylcholine Receptor M4 Production, Revenue (2018-2022)
14.6.4 Strategic initiatives
15. Conclusion
16. Methodology and Data Source


List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of Muscarinic Acetylcholine Receptor M4 Industry (Volume)
Figure 2. Muscarinic Acetylcholine Receptor M4 Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by Muscarinic Acetylcholine Receptor M4 Revenue in 2022
Figure 5. US Muscarinic Acetylcholine Receptor M4 Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Muscarinic Acetylcholine Receptor M4 Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Muscarinic Acetylcholine Receptor M4 Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Muscarinic Acetylcholine Receptor M4 Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Muscarinic Acetylcholine Receptor M4 Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Muscarinic Acetylcholine Receptor M4 Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Muscarinic Acetylcholine Receptor M4 Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Muscarinic Acetylcholine Receptor M4 Revenue, by Type (Million USD) (2018-2028)
Table 4. Muscarinic Acetylcholine Receptor M4 Production, by Type (K Unit) (2018-2028)
Table 5. Muscarinic Acetylcholine Receptor M4 Demand (K Unit) by Application (2018-2028)
Table 6. Muscarinic Acetylcholine Receptor M4 Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top Muscarinic Acetylcholine Receptor M4 Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Muscarinic Acetylcholine Receptor M4 Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Muscarinic Acetylcholine Receptor M4 Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Muscarinic Acetylcholine Receptor M4 Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Muscarinic Acetylcholine Receptor M4 Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Muscarinic Acetylcholine Receptor M4 Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Muscarinic Acetylcholine Receptor M4 Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Muscarinic Acetylcholine Receptor M4 Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Muscarinic Acetylcholine Receptor M4 in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Muscarinic Acetylcholine Receptor M4 in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Muscarinic Acetylcholine Receptor M4 in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Muscarinic Acetylcholine Receptor M4 in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Muscarinic Acetylcholine Receptor M4 in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Muscarinic Acetylcholine Receptor M4 in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Muscarinic Acetylcholine Receptor M4 in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Anavex Life Sciences Corp Profiles
Table 61. Anavex Life Sciences Corp Muscarinic Acetylcholine Receptor M4 Product Introduction
Table 62. Anavex Life Sciences Corp Muscarinic Acetylcholine Receptor M4 Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. Anavex Life Sciences Corp Strategic initiatives
Table 64. AstraZeneca Plc Profiles
Table 65. AstraZeneca Plc Muscarinic Acetylcholine Receptor M4 Product Introduction
Table 66. AstraZeneca Plc Muscarinic Acetylcholine Receptor M4 Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. AstraZeneca Plc Strategic initiatives
Table 68. Heptares Therapeutics Ltd Profiles
Table 69. Heptares Therapeutics Ltd Muscarinic Acetylcholine Receptor M4 Product Introduction
Table 70. Heptares Therapeutics Ltd Muscarinic Acetylcholine Receptor M4 Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. Heptares Therapeutics Ltd Strategic initiatives
Table 72. Karuna Pharmaceuticals Inc Profiles
Table 73. Karuna Pharmaceuticals Inc Muscarinic Acetylcholine Receptor M4 Product Introduction
Table 74. Karuna Pharmaceuticals Inc Muscarinic Acetylcholine Receptor M4 Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. Karuna Pharmaceuticals Inc Strategic initiatives
Table 76. NeuroHealing Pharmaceuticals Inc Profiles
Table 77. NeuroHealing Pharmaceuticals Inc Muscarinic Acetylcholine Receptor M4 Product Introduction
Table 78. NeuroHealing Pharmaceuticals Inc Muscarinic Acetylcholine Receptor M4 Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. NeuroHealing Pharmaceuticals Inc Strategic initiatives
Table 80. Sumitomo Dainippon Pharma Co Ltd Profiles
Table 81. Sumitomo Dainippon Pharma Co Ltd Muscarinic Acetylcholine Receptor M4 Product Introduction
Table 82. Sumitomo Dainippon Pharma Co Ltd Muscarinic Acetylcholine Receptor M4 Production (Unit), Revenue (Million USD) (2018-2022)
Table 83. Sumitomo Dainippon Pharma Co Ltd Strategic initiatives

Select User License

$4850 Single Licence
$5850 Enterprise Licence
$6850 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries